Clinical Trial Update: Dendritic Cell Based Therapy for Breast Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial of a dendritic cell–based therapy for breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Dendritic cell-based therapy

Snippet

Sponsor: Inge Marie Svane | Conditions: Breast Cancer | Phase 2 | Status: WITHDRAWN